News Novartis takes option on NASH drug from Conatus Swiss pharma takes option on FXR agonist emricasan.
News AbbVie takes aim at Gilead and BMS with 8-week hep C treatme... Trial backs patient-friendly regime in tough to treat strain.
Gilead Wales experts back HIV prophlyaxis, ahead of key meetings Cost-effectiveness bodies in Wales and Scotland to decide on Truvada in April.
News Pfizer under investigation over links with charities US authorities probing several other drugmakers amid pricing row.
News Is BMS the next pharma takeover target? Speculation mounting that Pfizer and others could try for $90 bn plus merger
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
